Robin Besuyen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Ankylosing Spondylitis

Top Venues

Rheumatology and therapy

The Journal of rheumatology

Annals of the rheumatic diseases

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Walter Reinisch, Wayne Hellstrom, Radboud J E M Dolhain, Suresh Sikka, René Westhovens, Rajiv Mehta, Timothy Ritter, Ursula Seidler, Oleksandr Golovchenko, Vladimir Simanenkov, Olena Garmish, Sławomir Jeka, Radka Moravcová, Vijay Rajendran, Franck-Olivier Le Brun, Sarah Arterburn, Timothy R Watkins, Robin Besuyen, Dirk Vanderschueren
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies. Annals of the rheumatic diseases (2023)
Bernard G Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, Maya H Buch
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis. Rheumatology and therapy (2022)
Arthur Kavanaugh, Rene R Westhovens, Kevin L Winthrop, Susan J Lee, YingMeei Tan, Di An, Lei Ye, John S Sundy, Robin Besuyen, Luc Meuleners, Mykola Stanislavchuk, Alberto J Spindler, Maria Greenwald, Rieke E Alten, Mark C Genovese
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs. The Journal of rheumatology 48 (8) (2021)
Walter P Maksymowych, Mikkel Østergaard, Robert B M Landewe, William Barchuk, Ke Liu, Leen Gilles, Thijs Hendrikx, Robin Besuyen, Xenofon Baraliakos
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial. Rheumatology (Oxford, England) (2021)